CellaVision AB (publ) (CLVSF)

Market Cap	404.89M -14.3%
Revenue (ttm)	79.43M +1.5%
Net Income	16.07M +0.8%
EPS	0.67 +0.8%
Shares Out	n/a
PE Ratio	25.20
Forward PE	20.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	438
Open	15.85
Previous Close	15.45
Day's Range	15.85 - 15.85
52-Week Range	15.45 - 17.30
Beta	1.30
RSI	41.82
Earnings Date	Feb 5, 2026

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 231
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLVSF

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.

Financial numbers in SEK